glp 1 ra Comprehensive Overview of GLP-1 RAs in Cardiometabolic Care Generic Liraglutide Approved, Marking First

Ongoing phase 3 trials are in progress, and CagriSema is currently under FDA review, with a decision expected in late 2026

This week: tirzepatide vs semaglutide results from 20,000+ patients, new data on the start-and-stop journey, groundbreaking research on GLP-1s rewiring impulsive behaviour, and why your step count matters more than you think.Plus Father's Day waffle, World Cup chat, and the first ever fully integrated sponsor on the channel.This week's stories: Tirzepatide vs Semaglutide: Real-world data from 20,000+ patients The Start & Stop trend 58% restart within 2 years GLP-1s and impulsive behaviour: the brain rewiring study Physical activity drop & the muscle loss warning Check out all the update videos on YouTube: YouTube Weekly Videos *The episodes in this series are recorded as YouTube videos

Taking them at the same time is not harmful, but the timing strategy provides more consistent bowel regulation

Schedule a Peptide Therapy Consultation Tucson Wellness MD serves patients in Tucson, Vail, Oro Valley, and Marana who want medically supervised peptide support for recovery, sleep, metabolism, hormone health, and body composition

Its important to talk with your doctor if youre taking medication and are interested in trying polyphenol supplements

Research shows 56% of patients on GLP-1RAs had much gastric content despite following standard fasting guidelines, while only 19% of non-users showed similar results [33]